Evidence map›Paper›PMID 35346329›Full record

ArticleTrials2022

Social network-based group intervention to promote HIV prevention in Uganda: study protocol for a cluster randomized controlled trial of Game Changers.

Glenn J Wagner, Laura M Bogart, Harold D Green, Erik D Storholm, David J Klein, Ryan K McBain, Richard Serunkuuma, Kuraish Mubiru, Joseph K B Matovu, Stephen Okoboi

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05098015 (Controlled Trial of Game Changers), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05098015 nacompletednot on this map

Controlled Trial of Game Changers: A Group Intervention to Train HIV Clients to be Change Agents for HIV Prevention in Uganda

TypeinterventionalSponsorRANDRan2022 to 2024Enrolled809ConditionsHIV PreventionArmsGame Changers
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Glenn J Wagner *RAND Corporation, 1776 Main Street, P.O. Box 2138, Santa Monica, CA, 90407-2138, USA. gwagner@rand.org.ORCID http://orcid.org/0000-0001-9081-3299
Laura M Bogart *RAND Corporation, 1776 Main Street, P.O. Box 2138, Santa Monica, CA, 90407-2138, USA.
Harold D GreenIndiana University School of Public Health, Bloomington, IN, USA.
Erik D StorholmSan Diego State University, San Diego, CA, USA.
David J KleinRAND Corporation, 1776 Main Street, P.O. Box 2138, Santa Monica, CA, 90407-2138, USA.
Ryan K McBainRAND Corporation, 1776 Main Street, P.O. Box 2138, Santa Monica, CA, 90407-2138, USA.
Richard SerunkuumaInfectious Diseases Institute, College of Health Sciences, National Forum of People Living with HIV/AIDS Networks in Uganda, Kampala, Uganda.
Kuraish MubiruInfectious Diseases Institute, College of Health Sciences, National Forum of People Living with HIV/AIDS Networks in Uganda, Kampala, Uganda.
Joseph K B Matovu *School of Public Health, Makerere University, Kampala, Uganda.
Stephen Okoboi *Infectious Diseases Institute, College of Health Sciences, Kampala, Uganda.
RAND Corporation · USInfectious Diseases Institute · UGBusitema University · UGIndiana University Bloomington · USSan Diego State University · US

Funding

UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Sung-Jae Lee · 1997 to 2026
$53.5M
Controlled Trial of Game Changers: A Group Intervention to Train HIV Clients to be Change Agents for HIV Prevention in UgandaR01MH126691 · NIMH · RAND CORPORATION · PI BOGART, LAURA M, WAGNER, GLENN JOHN · 2021 to 2025
$4.0M
NIMH NIH HHS P30 MH058107NIMH NIH HHS R01 MH126691NIMH NIH HHS R01MH126691
6 · The paper itself

Abstract

introductionInnovative strategies are needed to disseminate HIV prevention messages across communities efficiently, as well as reduce HIV stigma while promoting HIV prevention. This randomized controlled trial will evaluate the efficacy of a social network-based group intervention, Game Changers, which trains persons living with HIV (PLWH) to encourage members of their social network to use HIV protective behaviors

methodsPLWH in HIV care for at least 1 year will be randomly assigned to receive the 8-session group advocacy training intervention or no-intervention control group. Each enrolled PLWH (index participant) will be asked to recruit up to four social network members (alter participant). Assessments will be administered at baseline and months 6, 12, and 18 to both index and alter participants. The primary outcomes are HIV testing and condom use among alter participants; secondary outcomes are engagement in HIV prevention advocacy and internalized HIV stigma among index participants. Repeated-measures multivariable regression analyses will be conducted to compare outcomes between the intervention and control arms, in addition to a cost-effectiveness evaluation. DISCUSSION: This social network-based approach to HIV prevention is particularly timely in the era of biomedical interventions, which require widespread penetration of effective HIV prevention and care messaging into communities. Positioning PLWH as central to the solution for controlling (vs. causing) the HIV epidemic has the potential to reduce HIV stigma and improve prevention outcomes at the individual and network levels.

trial registrationClinicalTrials.gov NIH Clinical Trial Registry NCT05098015. Registered on October 18, 2021.

Indexed as

HIV InfectionsHumansRandomized Controlled Trials as TopicSocial NetworkingSocial StigmaUgandaCluster randomized controlled trialGroup interventionHIVPrevention advocacyUganda

Identifiers

PMID35346329
PMCPMC8961890
OpenAlexW4220791333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.